This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Kansas. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Alison Catherine Donnelly: Pioneering Innovations in Cancer Treatment
Introduction
Alison Catherine Donnelly, based in Grand Island, NY, is a notable inventor recognized for her significant contributions in the field of cancer research. With a strong focus on innovative solutions, she has developed a patented technology that addresses critical health issues.
Latest Patents
Donnelly is credited with one patent titled "Novobiocin analogues having modified sugar moieties." This invention provides novel novobiocin analogues equipped with noviose replacements that serve as Hsp90 inhibitors, showing promise in the treatment of cancer.
Career Highlights
Alison Donnelly is affiliated with the University of Kansas, where she has dedicated her career to advancing research and technology in pharmaceutical sciences. Her work is vital in developing therapies aimed at improving patient outcomes in oncology.
Collaborations
Throughout her career, Donnelly has collaborated with esteemed colleagues such as Brian S. J. Blagg and Huiping Zhao. These partnerships have fostered a rich environment for scientific inquiry and innovation, enabling the advancement of groundbreaking cancer treatments.
Conclusion
In summary, Alison Catherine Donnelly stands out as a pioneering inventor whose work in developing novobiocin analogues showcases her commitment to fighting cancer through innovative scientific research. Her contributions not only highlight her expertise but also shine a light on the importance of collaboration in the advancement of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile